Equillium (EQ) Free Cash Flow (2018 - 2026)
Equillium (EQ) posted quarterly Free Cash Flow of -$4.3 million for Q1 2026, up 47.34% year-over-year from -$2.9 million in Q1 2025, and down 35.47% quarter-over-quarter from -$3.2 million in Q4 2025.
Equillium (EQ) Free Cash Flow (2018 - 2026) Analysis & Trends
Equillium (EQ) has reported Free Cash Flow for 9 consecutive years, with -$4.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow rose 47.34% year-over-year to -$4.3 million; the TTM figure through Mar 2026 stood at -$18.9 million (down 2.49% YoY), while the FY2025 annual figure was -$22.8 million, down 19.27% from the prior year.
- Free Cash Flow declined to -$4.3 million in Q1 2026 per EQ's latest filing, from -$3.2 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $27.4 million in Q4 2022 and bottomed at -$12.8 million in Q3 2022.
- Historically, Free Cash Flow has averaged -$4.5 million across 5 years, with a median of -$6.2 million in 2023.
- Annual changes were most pronounced in 2022 — Free Cash Flow jumped 370.89% — and 2025, when it tumbled 551.05%.
- Equillium's Free Cash Flow stood at $27.4 million in 2022, then slumped by 120.76% to -$5.7 million in 2023, then soared by 42.04% to -$3.3 million in 2024, then rose by 3.81% to -$3.2 million in 2025, then slumped by 35.47% to -$4.3 million in 2026.
- Business Quant data shows EQ's Free Cash Flow at -$4.3 million in Q1 2026, -$3.2 million in Q4 2025, and -$8.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -389.61 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 437.80 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 477.44 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 292.04 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Equillium | 263.86 Mn | 263.86 Mn | - | -4.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.11 Mn |
| Jun 30, 2026 | -4.11 Mn |
| Mar 31, 2026 | -4.30 Mn |
| Mar 31, 2026 | -4.30 Mn |
| Dec 31, 2025 | -3.18 Mn |
| Dec 31, 2025 | -3.18 Mn |
| Sep 30, 2025 | -8.43 Mn |
| Sep 30, 2025 | -8.43 Mn |
| Jun 30, 2025 | -3.01 Mn |
| Jun 30, 2025 | -3.01 Mn |
| Mar 31, 2025 | -8.17 Mn |
| Mar 31, 2025 | -8.17 Mn |
| Dec 31, 2024 | -3.30 Mn |
| Dec 31, 2024 | -3.30 Mn |
| Sep 30, 2024 | -7.66 Mn |
| Sep 30, 2024 | -7.66 Mn |
| Jun 30, 2024 | 668,000.00 |
| Jun 30, 2024 | 668,000.00 |
| Mar 31, 2024 | -8.82 Mn |
| Mar 31, 2024 | -8.82 Mn |